Anu Muona is a founder and CEO of Aranda Pharma. Anu has over 7 years of experience on running preclinical drug discovery programs on cell therapy and small molecules. She has served as a Project manager of prostate cancer program at Medeia Therapeutics Ltd and been responsible for leading preclinical studies, building academic and CRO networks, participating in the strategic planning, IPR generation and partnering efforts. She has also been a member of a team exploring the potential of bone marrow stem cell-based therapy for the treatment of Alzheimer’s disease at Medeia Therapeutics Ltd. Anu has a strong scientific background in molecular biology and genetics. She received her PhD in molecular biology in the Collagen research unit of University of Oulu, Finland. She has completed extensive postdoctoral training in stem cell research and its applications in neurodegenerative diseases at the University of Eastern Finland, Kuopio.
Molecular biology